ArticleBioscience reports2019

Pristimerin inhibits glioma progression by targeting AGO2 and PTPN1 expression via miR-542-5p.

Zaiyu Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.